BNTC 13G

Company

Benitec Biopharma Inc.

Filed

February 9, 2021

Accession Number

0001393825-21-000015

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →